ANTCO. Investment Group AB has agreed to acquire a 2% stake in health-tech company Deversify AB for 1.1 million SEK, with the purchase being financed through a share issuance.

Target Information

ANTCO. Investment Group AB (publ) has recently reached an agreement to acquire a 2% ownership stake in the health-tech company Deversify AB. The total purchase price for this transaction amounts to 1.1 million SEK. This strategic acquisition will enable ANTCO. to enhance its portfolio in the health technology sector, tapping into the growing demand for innovative health solutions.

Deversify AB specializes in developing health technologies that aim to improve patient care and streamline healthcare processes. With a focus on innovation and sustainability, Deversify is positioned to play a significant role in transforming the healthcare landscape, making it an attractive entity for investors seeking growth opportunities in this sector.

Industry Overview

The health technology industry in Sweden has been experiencing substantial growth, influenced by advancements in technology and an increasing demand for efficient healthcare solutions. Sweden is recognized for its commitm

View Source

Similar Deals

ANTCO. Investment Group AB (publ) Dynamic Code AB (publ)

2025

Other Healthcare Facilities & Services (NEC) Sweden
Flerie AB Prokarium

2025

Other Bio Therapeutic Drugs Sweden
Flerie Toleranzia

2025

Other Biotechnology & Medical Research (NEC) Sweden
Flerie AB Toleranzia AB

2025

Other Biotechnology & Medical Research (NEC) Sweden
Asarina Pharma AB Asarina Pharma AB

2025

Other Bio Therapeutic Drugs Sweden
Flerie Invest Flerie AB

2024

Other Biotechnology & Medical Research (NEC) Sweden

ANTCO. Investment Group AB (publ)

invested in

Deversify AB

in 2025

in a Other deal

Disclosed details

Transaction Size: $0M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert